Virax Biolabs Group Ltd (VRAX) Assets (2021 - 2025)

Virax Biolabs (VRAX) has 4 years of Assets data on file, last reported at $6.4 million in Q1 2025.

• In Q1 2025, Assets rose 17.19% year-over-year to $6.4 million; the TTM figure through Mar 2025 stood at $21.7 million (changed N/A YoY), while the FY2025 annual figure was $6.4 million, up 17.19% from the prior year.
• Assets climbed to $6.4 million in Q1 2025, from $5.5 million in the prior quarter.
• Across five years, Assets topped out at $9.8 million in Q1 2023 and bottomed at $39621.0 in Q1 2021.
• A 4-year average of $5.4 million and a median of $6.0 million in 2024 frame the typical range for Assets.
• Annual changes were most pronounced in 2024 — Assets sank 44.11% — and 2025, when it grew 17.19%.
• Year by year, Assets stood at $39621.0 in 2021, then jumped by 24665.69% to $9.8 million in 2023, then slumped by 44.11% to $5.5 million in 2024, then increased by 17.19% to $6.4 million in 2025.
• The last three Assets figures came in at $6.4 million (Q1 2025), $5.5 million (Q1 2024), and $9.8 million (Q1 2023), per Business Quant data.

Peer Comparison